Haemophilus influenzae type b lipooligosaccharide induces meningeal inflammation.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Journal of Infectious Diseases

• Publication date

  1988-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/INFDIS/157.2.237PMID 3257246
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Conservation of epitopes in the oligosaccharide portion of the lipooligosaccharide of Haemophilus influenzae type b

  1987cited by this paper
• Protective Effect of Subinhibitory Polymyxin B Alone and in Combination with Ampicillin for Overwhelming Haemophilus influenzae Type B Infection in the Infant Rat: Evidence for in Vivo and in Vitro Release of Free Endotoxin after Ampicillin Treatment

  1986cited by this paper
• Lipopolysaccharide nomenclature--past, present, and future

  1986cited by this paper
• Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme.

  1986cited by this paper
• Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.

  1986cited by this paper
• Morphologic alterations of the blood-brain barrier with experimental meningitis in the rat. Temporal sequence and role of encapsulation.

  1986cited by this paper
• Antigenic and phenotypic variations of Haemophilus influenzae type b lipopolysaccharide and their relationship to virulence

  1986cited by this paper
• Antigenic heterogeneity of lipid A of Haemophilus influenzae

  1985cited by this paper
• The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis.

  1985cited by this paper
• Detection of free endotoxin in cerebrospinal fluid by the Limulus lysate test

  1984cited by this paper
• Complement (C5)-derived chemotactic activity accounts for accumulation of polymorphonuclear leukocytes in cerebrospinal fluid of rabbits with pneumococcal meningitis

  1984cited by this paper
• Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis.

  1984cited by this paper
• Enzymatic deacylation of the lipid A moiety of Salmonella typhimurium lipopolysaccharides by human neutrophils.

  1983cited by this paper
• Generation and release of DNA-binding vesicles by Haemophilus influenzae during induction and loss of competence

  1982cited by this paper
• A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.

  1982cited by this paper
• Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis

  1980cited by this paper
• The effects of bacterial endotoxins on host mediation systems. A review.

  1978cited by this paper
• Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

  1978cited by this paper
• Activation of the alternative complement pathway by Haemophilus influenzae type B

  1977cited by this paper
• Inhibition of the mitogenic response to lipopolysaccharide (LPS) in mouse spleen cells by polymyxin B.

  1977cited by this paper
• Improved techniques for the preparation of bacterial lipopolysaccharides.

  1976cited by this paper
• Cerebrospinal fluid endotoxin concentrations in gram-negative bacterial meningitis.

  1976cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• Observations on Experimental Meningitis in Rabbits

  1932cited by this paper

• The current approaches to modeling the brain ischemia–reperfusion and inflammation: from animal models toward vascularized and neuroimmune cerebral organoids

  2025cites this paper
• Structural studies of surfactant protein D in complex with bacterial lipopolysaccharide ligands

  2017cites this paper
• Chapter 97 – Haemophilus influenzae

  2015cites this paper
• Kill the Bacteria … and Also Their Messengers?

  2010cites this paper
• Toll-like receptors in bacterial meningitis.

  2009cites this paper
• Chapter 2: Kill the bacteria...and also their messengers?

  2009cites this paper
• Should we use dexamethasone in meningitis?

  2007cites this paper
• Role of glucocorticosteroids in the treatment of infectious diseases

  2006cites this paper
• Systemic inflammation alters the inflammatory response in experimental lipopolysaccharide‐induced meningitis

  2006cites this paper
• A historical perspective on pharmacological studies of gentamicin for therapy of neonatal meningitis.

  2006cites this paper
• The pathogenesis of disease due to type b Haemophilus influenzae.

  2003cites this paper
• Modulation of Release of Proinflammatory Bacterial Compounds by Antibacterials: Potential Impact on Course of Inflammation and Outcome in Sepsis and Meningitis

  2002cites this paper
• Functional genomics of pathogenic bacteria.

  2002cites this paper
• Pathogenesis of Haemophilus influenzae Infections

  2001cites this paper
• Systemic LPS injection leads to granulocyte influx into normal and injured brain: effects of ICAM-1 deficiency.

  2001cites this paper
• Haemophilus influenzae Porin Contributes to Signaling of the Inflammatory Cascade in Rat Brain

  2001cites this paper
• Advances in the use of carbapenem antibiotics in the management of serious bacterial infections in special patient populations. I: Safety and efficacy in children and elderly patients

  2000cites this paper
• Release of Teichoic and Lipoteichoic Acids from 30 Different Strains of Streptococcus pneumoniae during Exposure to Ceftriaxone, Meropenem, Quinupristin/Dalfopristin, Rifampicin and Trovafloxacin

  2000cites this paper
• Haemophilus influenzae lipopolysaccharide.

  1999cites this paper
• Antimicrobial and anti-inflammatory treatment of bacterial meningitis.

  1999cites this paper
• Polymyxin B Sulfate and Colistin: Old Antibiotics for Emerging Multiresistant Gram-Negative Bacteria

  1999cites this paper
• Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis.

  1999cites this paper
• Infant Rat Model of Acute Meningitis

  1999cites this paper
• Moxifloxacin in the Therapy of Experimental Pneumococcal Meningitis

  1998cites this paper
• Pharmacokinetic Optimisation of the Treatment of Bacterial Central Nervous System Infections

  1998cites this paper
• C-X-C and C-C chemokines are expressed in the cerebrospinal fluid in bacterial meningitis and mediate chemotactic activity on peripheral blood-derived polymorphonuclear and mononuclear cells in vitro.

  1997cites this paper
• The effect of interleukin-10 on meningeal inflammation in experimental bacterial meningitis.

  1997cites this paper
• Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis

  1997cites this paper
• Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis.

  1997cites this paper
• Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis.

  1996cites this paper
• The role of nitric oxide in bacterial meningitis in children.

  1996cites this paper
• Clindamycin therapy of experimental meningitis caused by penicillin- and cephalosporin-resistant Streptococcus pneumoniae

  1996cites this paper
• Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy

  1996cites this paper
• Hib-EuroSud'95: the South exists.

  1996cites this paper
• The lipooligosaccharides of pathogenic gram-negative bacteria.

  1996cites this paper
• Modulation of expression of genes involved in the inflammatory response by lipopolysaccharide and temperature in cultured human astroglial cells.

  1995cites this paper
• The cochlear lesion in experimental bacterial meningitis of the rabbit.

  1995cites this paper
• Dexamethasone treatment of lipopolysaccharide-induced meningitis in rabbits that mimics magnification of inflammation following antibiotic therapy.

  1995cites this paper
• Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis

  1995cites this paper
• The limited role of pneumolysin in the pathogenesis of pneumococcal meningitis.

  1995cites this paper
• Bacterial Meningitis

  1995cites this paper
• Toxicity of Streptococcus pneumoniae in neurons, astrocytes, and microglia in vitro.

  1995cites this paper
• Interleukin-1 beta in pleural fluids of different etiologies. Its role as inflammatory mediator in empyema.

  1995cites this paper
• Bacterial meningitis: Mechanisms of disease and therapy

  1995cites this paper
• Effect of interleukin-1 receptor antagonist and soluble tumor necrosis factor receptor in animal models of infection.

  1995cites this paper
• Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis

  1994cites this paper
• Cerebrospinal fluid interleukin-1 beta/interleukin-1 receptor antagonist balance and tumor necrosis factor-alpha concentrations in tuberculous, viral and acute bacterial meningitis.

  1994cites this paper
• Actinomycin D blocks interleukin-1 alpha-induced pial arteriolar dilation and increased prostanoid production in newborn pigs.

  1994cites this paper
• The pathophysiology of pneumococcal meningitis.

  1994cites this paper
• Rebound fever in bacterial meningitis: role of dexamethasone dosage.

  1994cites this paper
• The induction of meningeal inflammation and blood-brain barrier permeability by Haemophilus influenzae type b peptidoglycan.

  1994cites this paper
• Dexamethasone therapy for bacterial meningitis: Better never than late?

  1994cites this paper
• Dexamethasone therapy for bacterial meningitis in children: 2- versus 4-day regimen.

  1994cites this paper
• A functional tonB gene is required for both utilization of heme and virulence expression by Haemophilus influenzae type b

  1994cites this paper
• Dexamethasone therapy in bacterial meningitis.

  1994cites this paper
• Central Nervous System Infection in the Immunocompromised Host

  1994cites this paper
• Effect ofDexamethasone onTherapy ofExperimental Penicillin- andCephalosporin-Resistant

  1994cites this paper
• Pathogenesis and pathophysiology of bacterial meningitis

  1993cites this paper
• Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis.

  1993cites this paper
• Measurement of levels of tumor necrosis factor-alpha and interleukin-1 beta in the CSF of patients with meningitis of different etiologies: utility in the differential diagnosis.

  1993cites this paper
• New treatment strategies for bacterial meningitis.

  1993cites this paper
• Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli.

  1993cites this paper
• Evolving concepts in pediatric bacterial meningitis--Part I: Pathophysiology and diagnosis.

  1993cites this paper
• Toxicity in neuronal cells caused by cerebrospinal fluid from pneumococcal and gram-negative meningitis.

  1992cites this paper
• Current Concepts in Acute Purulent Meningitis

  1992cites this paper
• Plasma endotoxin and glycolipid antibodies in children with meningitis

  1992cites this paper
• Experimental rabbit model of meningitis produced by Haemophilus influenzae serotype c.

  1992cites this paper
• Should we use dexamethasone in meningitis? The Meningitis Working Party of the British Paediatric Immunology and Infectious Diseases Group.

  1992cites this paper
• Management of Bacterial Meningitis in Children and Adults

  1992cites this paper
• Virulent Treponema pallidum activates human vascular endothelial cells.

  1992cites this paper
• Compartmentalization of lipopolysaccharide production correlates with clinical presentation in meningococcal disease.

  1992cites this paper
• Adjunctive therapy in bacterial meningitis--what make sense?

  1992cites this paper
• Bacterial meningitis: pathogenesis, pathophysiology, and progress.

  1992cites this paper
• Outcome of paediatric bacterial meningitis 1979–1989

  1992cites this paper
• The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues.

  1992cites this paper
• The gal locus from Haemophilus influenzae: cloning, sequencing and the use of gal mutants to study lipopolysaccharide

  1992cites this paper
• Therapy of bacterial meningitis in children.

  1991cites this paper
• Molecular analysis of a complex locus from Haemophilus influenzae invoked in phase‐variable lipopolysaccharide biosynthesis

  1991cites this paper
• Enhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anti-CD18 monoclonal antibodies and dexamethasone in experimental Haemophilus meningitis.

  1991cites this paper
• In vivo and in vitro expression of Haemophilus influenzae type b lipooligosaccharide epitopes.

  1991cites this paper
• Genetics of Haemophilus influenzae lipopolysaccharide expression.

  1991cites this paper
• Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor.

  1991cites this paper
• Acute Therapy of Bacterial Meningitis

  1991cites this paper
• The role of Haemophilus influenzae in the pathogenesis of pneumonia.

  1991cites this paper
• Induction of suppurative arthritis in rabbits by Haemophilus endotoxin, tumor necrosis factor-alpha, and interleukin-1 beta.

  1991cites this paper
• A comparison of central nervous lesions directly induced by Escherichia coli lipopolysaccharide in piglets, calves, rabbits and mice.

  1991cites this paper
• Endotoxin induced damage to the cochlea in guinea pigs.

  1991cites this paper
• Molecular cloning of a gene involved in lipooligosaccharide biosynthesis and virulence expression by Haemophilus influenzae type B

  1991cites this paper
• Severity of childhood bacterial meningitis and duration of illness before diagnosis.

  1991cites this paper
• The role of corticosteroid therapy in children with pneumococcal meningitis.

  1991cites this paper
• Endotoxin concentrations in cerebrospinal fluid correlate with clinical severity and neurologic outcome of Haemophilus influenzae type B meningitis.

  1991cites this paper
• Adjunct therapy in bacterial meningitis.

  1991cites this paper
• Phase variation of lipopolysaccharide in Haemophilus influenzae.

  1991cites this paper
• Cytokines in the pathogenesis of bacterial meningitis.

  1991cites this paper
• Deacylated lipopolysaccharide inhibits plasminogen activator inhibitor-1, prostacyclin, and prostaglandin E2 induction by lipopolysaccharide but not by tumor necrosis factor-alpha.

  1990cites this paper
• Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

  1990cites this paper
• Bacterial meningitis: recent advances in pathophysiology and treatment.

  1990cites this paper
• Molecular pathophysiology of bacterial meningitis: current concepts and therapeutic implications.

  1990cites this paper
• Virulence attributes of the liposaccharides of the HAP group organisms.

  1990cites this paper
• Our understanding of the Pasteurellaceae.

  1990cites this paper